文献速递胃肠外科围术期管理与 ERAS

成人腹部大手术中高吸入氧浓度与标准吸入氧浓度对术后肺部并发症影响的非劣效性试验

Postoperative pulmonary complications with high versus standard FiO2 in adult patients undergoing major abdominal surgery: A noninferiority trial.
PubMed 文献 · Surgery · 2023-11-27

该非劣效性随机试验将226例成人腹部大手术患者分为高吸入氧浓度组(0.8)和标准吸入氧浓度组(0.3-0.4),均采用肺保护性通气策略。术后第3天和第5天墨尔本组量表评分两组统计学相似,且差异上界在预设界值1以内。高FiO2在术后肺部并发症方面非劣效于标准FiO2。

要点

  • 高FiO2组与标准FiO2组术后第3天墨尔本组量表评分中位数差异为0(95%CI 0,-1),P=0.13。
  • 术后第5天两组评分中位数差异为0(95%CI 0,0.5),P=0.34,差异上界在预设界值1以内。
  • 手术部位感染、术后住院时间和术后第28天无抗生素治疗存活天数两组相似。

核心结论

  • 在成人腹部大手术患者中,术中高FiO2在术后肺部并发症方面非劣效于标准FiO2。

研究设计与样本

  • 非劣效性随机试验,纳入226例成人择期或急诊腹部大手术患者。

主要发现

  • 术后第3天墨尔本组量表评分中位数:标准FiO2组2(四分位距1-4)vs 高FiO2组2(四分位距1-3),中位数差异0(95%CI 0,-1),P=0.13。
  • 术后第5天墨尔本组量表评分中位数:标准FiO2组1(四分位距0-3)vs 高FiO2组1(四分位距0-3),中位数差异0(95%CI 0,0.5),P=0.34。
  • 手术部位感染发生率P=0.46,术后住院时间P=0.29,术后第28天无抗生素治疗存活天数P=0.95,两组相似。

关键数值与推荐

  • 术中高FiO2为0.8(H组),标准FiO2为0.3-0.4(S组)。
  • 所有患者采用肺保护性通气策略:容量控制通气,潮气量6-8 mL/kg预测体重,呼吸频率12次/分,呼气末正压5-8 cm H2O。
  • 术后肺部并发症通过墨尔本组量表在术后第3天和第5天评估。
  • 非劣效界值为1。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite the possible clinical benefit of high intraoperative oxygen therapy on surgical site infection, the effect on postoperative respiratory function is debatable. However, it remains yet to be elucidated whether hyperoxia due to a high fraction of inspired oxygen used in conjunction with lung protective ventilation can lead to increased incidence of postoperative pulmonary complications. METHODS: In this noninferiority randomized trial, an intraoperative high fraction of inspired oxygen of 0.8 (group H) was compared to a standard fraction of inspired oxygen of 0.3 to 0.4 (group S) in adult patients undergoing major elective or emergency surgery. A lung protective ventilation strategy was employed in all patients, including volume control ventilation with a tidal volume of 6 to 8 mL/kg of predicted body weight, respiratory rate of 12 beats per minute, and positive end-expiratory pressure of 5 to 8 cm H2O. Postoperative pulmonary complications were assessed on postoperative days 3 and 5 by the Melbourne group scale. RESULTS: In this trial, n = 226 patients were randomized; among them, 130 patients underwent routine surgery, and 96 patients underwent emergency surgery. The median (interquartile range) of the patients was 48 (35-58) years, and 47.3% were female. Melbourne group scale scores at postoperative day 3 (median [interquartile range] 2 [1-4] in group S vs 2 [1-3] in group H; the difference in median [95% confidence interval] 0 [0, -1]; P = .13) and day 5 (median [interquartile range] 1 (0-3) in group S vs 1 [0-3] in group H; the difference in median [95% confidence interval] 0 [0, 0.5]; P = .34) were statistically similar in both the groups and the upper margin was within the predefined margin of 1. Incidence of surgical site infection (P = .46), postoperative hospital stay (P = .29), and days alive without antibiotic therapy at postoperative day 28 (P = .95) were similar in both groups. CONCLUSION: High intraoperative fiO2 was noninferior to standard fiO2 in postoperative pulmonary complications in adult patients undergoing major surgery.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Kochupurackal JC, Bhattacharjee S, Baidya DK, et al. Postoperative pulmonary complications with high versus standard FiO2 in adult patients undergoing major abdominal surgery: A noninferiority trial. Surgery. 2023. PMID: 38016902. doi:10.1016/j.surg.2023.10.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。